Anuncio
Mercados españoles cerrados en 7 hrs 50 min
  • IBEX 35

    10.977,80
    +87,60 (+0,80%)
     
  • Euro Stoxx 50

    4.970,49
    +33,64 (+0,68%)
     
  • Dólar/Euro

    1,0686
    +0,0030 (+0,28%)
     
  • Petróleo Brent

    87,27
    +0,27 (+0,31%)
     
  • Oro

    2.322,90
    -23,50 (-1,00%)
     
  • Bitcoin EUR

    61.921,17
    +1,06 (+0,00%)
     
  • CMC Crypto 200

    1.397,78
    -16,97 (-1,20%)
     
  • DAX

    18.011,16
    +150,36 (+0,84%)
     
  • FTSE 100

    8.072,79
    +48,92 (+0,61%)
     
  • S&P 500

    5.010,60
    +43,37 (+0,87%)
     
  • Dow Jones

    38.239,98
    +253,58 (+0,67%)
     
  • Nasdaq

    15.451,31
    +169,30 (+1,11%)
     
  • Petróleo WTI

    82,19
    +0,29 (+0,35%)
     
  • EUR/GBP

    0,8641
    +0,0017 (+0,20%)
     
  • Plata

    26,96
    -0,29 (-1,05%)
     
  • NIKKEI 225

    37.552,16
    +113,55 (+0,30%)
     

Moderna's Coronavirus Vaccine to Be Reviewed by FDA Advisory Committee on Dec. 17

Moderna's Coronavirus Vaccine to Be Reviewed by FDA Advisory Committee on Dec. 17

Moderna (NASDAQ: MRNA) reported complete data for its coronavirus vaccine candidate, mRNA-1273, today. It also submitted its application for emergency use authorization to the Food and Drug Administration (FDA). Investors will have to wait a few weeks to see what the agency thinks of the data package.